Search

Saved articles

You have not yet added any article to your bookmarks!

Newsletter image

Subscribe to the Newsletter

Join 10k+ people to get notified about new posts, news and tips.

Do not worry we don't spam!

Abu Dhabi Biobank Collaborates with AstraZeneca to Enhance Precision Medicine

Abu Dhabi Biobank Collaborates with AstraZeneca to Enhance Precision Medicine

Post by : Badri Ariffin

Abu Dhabi Biobank, a collaboration initiative led by the Department of Health – Abu Dhabi and M42, has entered into a partnership with global biopharmaceutical leader AstraZeneca to propel advancements in precision medicine and clinical research.

This collaboration merges Abu Dhabi Biobank's innovative biobanking, genomic capabilities, and population health metrics with AstraZeneca’s extensive expertise in critical therapy fields such as cardiovascular, renal, metabolic, respiratory, immunology, and oncology. The primary aim is to convert scientific research into health solutions.

Both organisations will jointly pursue various strategic focuses such as clinical development, precision medicine, and generating real-world evidence. Their efforts will enhance biomarker discovery, pharmacogenomics, and better patient stratification, enabling healthcare professionals to gain deeper insights into diseases and tailor treatments accordingly.

Additionally, this partnership will delve into health economics, regulatory science, and emerging domains like digital health and artificial intelligence. These initiatives are designed to fortify data-driven healthcare infrastructures and expedite the transition of research findings into clinical applications.

Albarah ElKhani, COO of Integrated Health Solutions at M42, expressed that the alliance signifies a mutual objective to redefine the future of medicine. He pointed out that blending comprehensive population data from Abu Dhabi Biobank with AstraZeneca’s scientific knowledge could unlock new avenues in disease prevention, diagnosis, and treatment, particularly for Middle Eastern demographics.

Sameh ElFangary, Country President for Gulf and Pakistan at AstraZeneca, emphasized that precision medicine should embody the diversity of populations worldwide. He mentioned that this collaboration will aid in the earlier identification of at-risk patients, especially in the context of rare and difficult-to-diagnose illnesses, contributing to the development of more tailored care plans.

This partnership signifies a key development in Abu Dhabi's ambition to establish itself as a leading center for biomedical research and life sciences innovation. By leveraging extensive population data and local insights, the collaboration seeks to hasten the journey from research discovery to regulatory endorsement and real-world application.

Jan. 15, 2026 3:32 p.m. 436

#Global News

Singapore Reviews New US Chip Export Controls Targeting China
Nov. 17, 2026 11:34 a.m.
Singapore reviews US chip export restrictions targeting China's AI access, raising concerns for semiconductor trade and data centre businesses
Read More
APEC Members Emphasise Safe and Responsible Use of Artificial Intelligence
Nov. 17, 2026 10:24 a.m.
APEC members discuss responsible AI use, digital innovation and data governance as China and the US compete for global AI leadership
Read More
Union of European Clubs Challenge UEFA and EFC Over EU Competition Rules
Nov. 16, 2026 5:18 p.m.
UEC files an EU competition complaint against UEFA and EFC, challenging club representation, governance rights and decision-making powers
Read More
US Dollar Extends Rally as Yen Faces Pressure After Weak GDP
Nov. 16, 2026 4:29 p.m.
The US dollar reaches a 19-month high as traders assess Fed rate signals, weak Japan GDP data and possible yen intervention
Read More
Sheikh Hasina Plans December Return to Bangladesh Despite Death Threat
Nov. 16, 2026 3:35 p.m.
Sheikh Hasina plans to return to Bangladesh in December despite death threats, a death sentence and growing political tensions with Dhaka
Read More
Trump Plans to Name Nvidia and AI Firms US National Champions
Nov. 16, 2026 10:01 a.m.
Trump administration plans to name Nvidia, Amazon, Microsoft and OpenAI among US AI national champions to expand overseas and compete with China
Read More
Mohammed Shami Retires From Test Cricket, Eyes White-Ball Career
Nov. 7, 2026 11:10 a.m.
Mohammed Shami retires from Test cricket after 13 years, with 229 wickets. He will continue playing white-ball cricket and domestic matches
Read More
Najib Razak Leaves Prison to Serve Remaining Sentence at Home
Nov. 6, 2026 2:22 p.m.
Najib Razak leaves Kajang Prison after payment of a RM50 million fine, allowing Malaysia's former PM to serve his remaining sentence at home
Read More
Singapore Warns Users About Privacy and Security Risks of AI Agents
Nov. 6, 2026 12:50 p.m.
Singapore warns users about AI agent security risks, data privacy, online scams and unauthorised access to personal accounts
Read More
Trending News